NO20043951L - 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler - Google Patents

3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler

Info

Publication number
NO20043951L
NO20043951L NO20043951A NO20043951A NO20043951L NO 20043951 L NO20043951 L NO 20043951L NO 20043951 A NO20043951 A NO 20043951A NO 20043951 A NO20043951 A NO 20043951A NO 20043951 L NO20043951 L NO 20043951L
Authority
NO
Norway
Prior art keywords
antibacterial agents
formula
cyclyl
nitrogen
membered ring
Prior art date
Application number
NO20043951A
Other languages
English (en)
Norwegian (no)
Other versions
NO20043951D0 (no
Inventor
Michael Barry Gravestock
Neil James Hales
Folkert Reck
Fei Zhou
Paul Robert Fleming
Daniel Robert Carcanague
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20043951D0 publication Critical patent/NO20043951D0/no
Publication of NO20043951L publication Critical patent/NO20043951L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20043951A 2002-02-28 2004-09-21 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler NO20043951L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36068802P 2002-02-28 2002-02-28
PCT/GB2003/000791 WO2003072576A2 (en) 2002-02-28 2003-02-25 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO20043951D0 NO20043951D0 (no) 2004-09-21
NO20043951L true NO20043951L (no) 2004-11-11

Family

ID=27766238

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043951A NO20043951L (no) 2002-02-28 2004-09-21 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler

Country Status (20)

Country Link
US (1) US7199143B2 (es)
EP (1) EP1480975A2 (es)
JP (1) JP2005531504A (es)
KR (1) KR20040086465A (es)
CN (1) CN1653064A (es)
AR (1) AR039559A1 (es)
AU (1) AU2003209994A1 (es)
BR (1) BR0308018A (es)
CA (1) CA2477379A1 (es)
CO (1) CO5601010A2 (es)
IL (1) IL163643A0 (es)
IS (1) IS7424A (es)
MX (1) MXPA04008273A (es)
NO (1) NO20043951L (es)
NZ (1) NZ535591A (es)
PL (1) PL372090A1 (es)
RU (1) RU2004129278A (es)
TW (1) TW200403241A (es)
WO (1) WO2003072576A2 (es)
ZA (1) ZA200406684B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1427711E (pt) 2001-09-11 2005-11-30 Astrazeneca Ab Derivados de oxazolidinona e/ou isoxazolina como agentes antibacterianos
US7022705B2 (en) 2001-10-25 2006-04-04 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
BR0308056A (pt) * 2002-02-28 2004-12-07 Astrazeneca Ab Composto, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
CA2507628A1 (en) * 2002-11-28 2004-06-10 Astrazeneca Ab Oxazolidinones as antibacterial agents
GB0306358D0 (en) 2003-03-20 2003-04-23 Astrazeneca Ab Chemical compounds
WO2005042523A1 (en) * 2003-11-03 2005-05-12 Il-Dong Pharm. Co., Ltd. A novel oxazolidinone derivative and manufacturing process thereof
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
DE602006010702D1 (de) 2005-06-29 2010-01-07 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
US8084477B2 (en) 2007-10-31 2011-12-27 Bristol-Myers Squibb Company Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
WO2010042887A2 (en) 2008-10-10 2010-04-15 Trius Therapeutics Methods for preparing oxazolidinones and compositions containing them
AU2010210627B2 (en) 2009-02-03 2016-03-03 Merck Sharp & Dohme Llc Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
CN101792437B (zh) * 2010-03-10 2012-01-25 天津药物研究院 一类三氮唑的衍生物、其制备方法和用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260948A (en) * 1984-12-05 1989-09-26 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
GB9521508D0 (en) 1995-10-20 1995-12-20 Zeneca Ltd Chemical compounds
GB9601666D0 (en) 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9604301D0 (en) 1996-02-29 1996-05-01 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9614236D0 (en) 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
GB9614238D0 (en) 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
JP2001514259A (ja) 1997-08-29 2001-09-11 ゼネカ・リミテッド アミノメチルオキソオキサゾリジニルベンゼン誘導体
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
TR200003595T2 (tr) 1998-06-05 2001-07-23 Astrazeneca Ab Kimyasal bileşikler
GB9812019D0 (en) 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
GB9821938D0 (en) 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
GB9928499D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical processes and intermediates
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
KR20020072311A (ko) 2000-02-10 2002-09-14 파마시아 앤드 업존 캄파니 피페라진 아미드 치환기를 갖는 옥사졸리디논 티오아미드
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6277868B1 (en) * 2000-08-31 2001-08-21 Abbott Laboratories Oxazolidinone chemotherapeutic agents
JP3972575B2 (ja) 2000-11-02 2007-09-05 株式会社日立製作所 ドアシステム
ES2268011T3 (es) 2001-04-07 2007-03-16 Astrazeneca Ab Oxazolidinonas que contienen un grupo sulfonimida como antibioticos.
GB0108794D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compound
GB0108793D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108764D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0113300D0 (en) 2001-06-01 2001-07-25 Astrazeneca Ab Purification process
GB0113299D0 (en) 2001-06-01 2001-07-25 Astrazeneca Ab Chemical process & intermediates
GB0113297D0 (en) 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
GB0121490D0 (en) 2001-09-05 2001-10-24 Smithkline Beecham Plc Ciompounds
PT1427711E (pt) 2001-09-11 2005-11-30 Astrazeneca Ab Derivados de oxazolidinona e/ou isoxazolina como agentes antibacterianos
US7022705B2 (en) 2001-10-25 2006-04-04 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
US20050043374A1 (en) 2001-10-25 2005-02-24 Gravestock Michael Barry Aryl substituted oxazolidinones with antibacterial activity
CA2507628A1 (en) 2002-11-28 2004-06-10 Astrazeneca Ab Oxazolidinones as antibacterial agents
AU2003302404B2 (en) 2002-11-28 2008-06-19 Astrazeneca Ab Oxazolidinone and / or isoxazoline derivatives as antibacterial agents
GB0227701D0 (en) 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds
GB0229522D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229518D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229521D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229526D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
TW200500360A (en) 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
GB0306357D0 (en) 2003-03-20 2003-04-23 Astrazeneca Ab Chemical compounds
GB0306358D0 (en) 2003-03-20 2003-04-23 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
CO5601010A2 (es) 2006-01-31
MXPA04008273A (es) 2004-11-10
US20050182112A1 (en) 2005-08-18
AU2003209994A1 (en) 2003-09-09
ZA200406684B (en) 2005-09-21
RU2004129278A (ru) 2005-06-10
CA2477379A1 (en) 2003-09-04
TW200403241A (en) 2004-03-01
WO2003072576A2 (en) 2003-09-04
AR039559A1 (es) 2005-02-23
NZ535591A (en) 2006-07-28
NO20043951D0 (no) 2004-09-21
IS7424A (is) 2004-08-26
PL372090A1 (en) 2005-07-11
US7199143B2 (en) 2007-04-03
BR0308018A (pt) 2005-01-04
CN1653064A (zh) 2005-08-10
IL163643A0 (en) 2005-12-18
JP2005531504A (ja) 2005-10-20
WO2003072576A3 (en) 2003-12-31
KR20040086465A (ko) 2004-10-08
EP1480975A2 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
NO20043951L (no) 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler
NO20084382L (no) Sykloalkylaminosyrederivater og farmasoytiske sammensetninger derav
NO20025091L (no) Oksazolidinonderivater med antibiotisk aktivitet
NO20053133L (no) Kjemiske forbindelser.
UA41251C2 (uk) Гідровані азотвмісні гетероциклічні сполуки, похідні піперидину, фармацевтична композиція та спосіб пригнічення активності речовини р в організмі
NO20085169L (no) Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20092314L (no) Benzamidderivater som EP4 receptoragonister
NO20085269L (no) 2-tioksantinderivater som fungerer som MPO-inhibitorer
MXPA05009205A (es) Derivados de dihidroxiisoxasol hidroximetil sustituidos utiles como agentes antibioticos.
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
TW200626553A (en) Novel compounds
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
NO20092689L (no) Quinuclidinolderivater som muskarin reseptorantagonister
YU52403A (sh) Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
NO20061584L (no) Substituerte 2-karbonylamino-6-piperidinaminopyridiner og substituerte 1-karbonylamino-3-piperidinaminobenzener som 5-HT1F agonister
NO20075617L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet
DK1425280T3 (da) Kemiske forbindelser
ATE199549T1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
HUP0303204A2 (hu) 1-Metilkarbapenem-származékok és ezeket tartalmazó gyógyszerkészítmények
NO20052360L (no) Forbedrede formuleringer inneholdende substituerte imidazolderivater
RU2004130284A (ru) Антипаразитарные производные артемизинина (эндопероксиды)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application